Daw-Tsun Shih

Title: The Innovations of Daw-Tsun Shih

Introduction

Daw-Tsun Shih is a notable inventor based in Ridgefield, CT (US). He has made significant contributions to the field of biotechnology, particularly in the development of compounds targeting specific proteins involved in inflammatory processes. With a total of 3 patents, his work has implications for therapeutic applications in various diseases.

Latest Patents

One of his latest patents is focused on compounds that target IL-23A and TNF-alpha. The disclosure relates to compounds specific for IL-23A and TNF-alpha, compositions comprising these compounds, and methods of use thereof. Additionally, nucleic acids, cells, and methods of production related to the compounds and compositions are also disclosed. This innovative approach has the potential to advance treatment options for conditions associated with these inflammatory markers.

Career Highlights

Daw-Tsun Shih has worked with prominent companies in the biotechnology sector, including Boehringer Ingelheim International GmbH and Macrogenics, Inc. His experience in these organizations has allowed him to collaborate on various projects that push the boundaries of current medical research.

Collaborations

Some of his notable coworkers include Rachel Rebecca Barrett and Leslie Sydnor Johnson. Their collaborative efforts have contributed to the advancement of research in their respective fields.

Conclusion

Daw-Tsun Shih's innovative work in targeting IL-23A and TNF-alpha showcases his commitment to advancing biotechnology. His contributions through patents and collaborations highlight the importance of research in developing new therapeutic strategies.